| Drug Name | aldoxorubicin |
|---|---|
| Other Drug Names | CYT387 |
| Chemical Name | N'-[(1E)-1-{(2S,4S)-4-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl) oxy]-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl}-2-hydroxyethylidene]-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanohydrazide |
| Formula | C37H42N4O13 |
| Mol. Wt. | 750.7 |
| CAS No. | 1361644-26-9 |
| UNII | C28MV4IM0B |
| Target-based Actions | Topoisomerase II inhibitor |
| ATC Codes | L01DB |
| Highest Status | 临床三期 |
| Originator Company | CytRx Corp. |
| Structure |
 |
Extended Information